Mark Agulnik, Jason K. Sicklick, Shreyaskumar Patel, Mrinal M. Gounder, Suzanne George, Rashmi Chugh, Michael C. Heinrich, David A. Liebner, Vaia Florou, John Markus Rieth, Pedro Viveiros, Daruka Mahadevan, Arun S. Singh, Vanessa Anne Eulo, Jonathan C. Trent, Xiaoxian Dai, Ramya Antony, Daniel Corum, Mollie Leoni, Margaret von Mehren. "Phase 1a/1b study of the safety, pharmacokinetics, and antitumor activity of ziftomenib in combination with imatinib in patients with advanced gastrointestinal stromal tumors (GIST) after imatinib failure.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps11589